Common Stock | Note 11 - Common Stock On March 17, 2023, we issued 2,465,816 0.863 2,128,000 On April 18, 2023, we issued 20,000 3.00 On April 24, 2023, we issued 70,000 1.64 On July 17, 2023, the Company issued 121,422 1.75 On August 3, 2023, the Company issued 260,000 3.00 On August 3, 2023, the Company issued 12,500 2.47 On September 5, 2023, the Company issued 2,500 2.47 70,000 1.64 On September 14, 2023, two officers of the Company exercised an aggregate of 180,400 90,898 89,502 On March 29, 2024, the Company issued 17,500 2.80 On March 29, 2024, the Company issued 150,000 2.15 As of May 28, 2024, the Company has received $ 775,000 310,000 2.50 As of May 31, 2024 there were 52,712,850 Share Purchase Warrants A continuity schedule of outstanding share purchase warrants as at May 31, 2024, and the changes during the periods, is as follows: Schedule of outstanding share purchase warrants Number of Weighted Average Balance, February 28, 2023 2,287,480 $ 3.32 Exercised (20,000 ) $ 3.00 Expired (188,500 ) $ 2.00 Exercised (260,000 ) $ 3.00 Expired (1,137,668 ) $ 3.00 Cashless Exercised (168,000 ) $ 1.75 Balance, May 31, 2024 513,312 $ 5.21 On April 18, 2023 60,000 20,000 3.00 On April 19, 2023, 188,500 2.00 On July 13, 2023, the Company received $ 780,000 260,000 3.00 On July 13, 2023, 1,137,668 3.00 On July 17, 2023, Benchmark 168,000 121,422 A summary of share purchase warrants outstanding and exercisable as at May 31, 2024 is as follows: Schedule of share purchase warrants outstanding and exercisable Number of Warrants Remaining Contractual Exercise Price Outstanding Life (Years) Expiry Date $ 5.00 350,000 0.30 September 19, 2024 $ 8.22 28,312 1.43 November 4, 2025 $ 6.70 10,000 1.48 November 21, 2025 $ 5.00 125,000 0.34 October 1,2024 $ 5.21 513,312 Stock Options On December 28, 2021, the Company granted an aggregate of 4,545,000 8.00 The fair value of these stock options was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions: Schedule of valuation assumptions May 31, February 29, 2024 Expected Risk-Free Interest Rate 1.06 % 1.06 % Expected Volatility 15.27 % 15.27 % Expected Life in Years 5.0 5.0 Expected Dividend Yield — — Weighted-Average Grant Date Fair Value $ 6.46 $ 6.46 On July 28, 2023, the Company granted an aggregate of 2,648,500 4.62 The fair value of these stock options was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions: Schedule of valuation assumptions May 31, 2024 February 29, 2024 Expected Risk-Free Interest Rate 5.37 % 5.37 % Expected Volatility 25.48 % 25.48 % Expected Life in Years 5.0 5.0 Expected Dividend Yield — — Weighted-Average Grant Date Fair Value $ 4.58 $ 4.58 A continuity schedule of outstanding stock options as at May 31, 2024, and the changes during the period, is as follows: Schedule of stock option activity Number of Stock Options Exercise Price Balance, February 28, 2022 4,545,000 $ 3.84 Cancelled/Forfeited (974,000 ) 3.84 Balance, February 28, 2023 3,571,000 $ 3.84 Stock Options Grant - July 28, 2023 2,648,500 4.62 Exercised (180,400 ) 3.84 Balance, May 31, 2024 6,039,100 $ 4.18 The table below sets forth the number of issued shares and cash received upon exercise of stock options: Schedule of number of issued shares and cash received upon exercise of stock options May 31, 2024 February 29, 2024 Number of Options Exercised on Forfeiture Basis — 89,502 Number of Options Exercised on Cash Basis — — Total Number of Options Exercised — 89,502 Number of Shares Issued on Cash Exercise — — Number of Shares Issued on Forfeiture Basis — 90,898 Total Number of Shares Issued Upon Exercise of Options — 90,898 Cash Received from Exercise of Stock Options $ — $ — Total Intrinsic Value of Options Exercised $ — $ — A continuity schedule of outstanding unvested stock options at May 31, 2024, and the changes during the three months periods, is as follows: Schedule of unvested restricted stock Number of Weighted Average Unvested Grant Date Balance, February 28, 2023 2,142,600 $ 6.46 Stock Options Grant - July 28, 2023 2,648,500 $ 4.58 Vested – July 28, 2023 (529,700 ) $ 4.58 Vested – December 28, 2023 (714,200 ) $ 6.46 Balance, May 31, 2024 3,547,200 $ 5.34 As at May 31, 2024, the aggregate intrinsic value of the outstanding stock options granted on December 28, 2021 was estimated at $0 as the current price as of May 31, 2024 is $3.14 which is lower than the strike price while the aggregate intrinsic value of the outstanding stock options granted on July 28, 2023 is $0 as the current price as of May 31, 2024 is lower than the strike price. A summary of stock options outstanding and exercisable as at May 31, 2024 is as follows: Schedule of stock options Options Outstanding Options Exercisable Range of Exercise Prices Outstanding at May 31, 2024 Exercise Price Weighted Average Remaining Contractual Term (Years) Exercisable at May 31, 2024 Exercise Price Weighted Average Remaining Contractual Term (Years) $ 7.00 9.00 3,390,600 $ 3.84 1.58 1,962,200 $ 3.84 1.58 $ 4.00 5.00 2,648,500 $ 4.62 3.16 529,700 $ 4.62 3.16 6,039,100 2,491,900 |